According to FutureWise analysis, the market for Addison's Disease Treatment is expected to grow at a CAGR of 10.70% over the forecast period of 2023-2031.
Primary adrenal insufficiency, another name for Addison's disease, is a rare chronic condition in which the adrenal glands, located at top of the kidneys, fail to generate enough cortisol and, occasionally, aldosterone. These hormones control several biological processes, including blood pressure regulation, electrolyte balance, and the body's reaction to stress. Adrenal gland malfunction or injury is the leading cause of Addison's disease. Inadvertent destruction of adrenal tissue can happen due to autoimmune reactions, where the body's immune system wrongly targets and destroys it. Infections, including tuberculosis or fungal infections, specific drugs, bleeding into the adrenal glands, or genetic factors, are examples of additional reasons. Clinical evaluation, reviewing medical history, and laboratory tests are essential for the diagnosis of Addison's disease. Laboratory blood tests are required to measure cortisol and adrenocorticotropic hormone (ACTH) levels, providing insight into the functioning of the adrenal glands. Additional diagnostic procedures, such as ACTH stimulation tests or imaging studies, are conducted to determine the underlying cause of adrenal insufficiency.
After diagnosis, the primary treatment for Addison's disease must be hormone replacement therapy, which aims to compensate for the deficient hormones in the body. Typically, this involves the administration of oral glucocorticoids, such as hydrocortisone or prednisone, and mineralocorticoids, like fludrocortisone, to restore cortisol and aldosterone levels. Dosages are regularly adjusted based on individual requirements, stress levels, and overall health conditions. The prevalence is 0.6 per 100,000 people annually. Addison’s disease affects somewhere between 4 and 11 individuals out of every 100,000 individuals at any particular moment. The typical age of symptomatic presentation in adults is between 30 and 50. Women are more likely to be diagnosed with it.
FutureWise Market Research has published a report that provides an insightful analysis of Addison's Disease Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes the stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, Addison's Disease Treatment Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition to providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organization to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.